Skip to main content
. Author manuscript; available in PMC: 2022 Aug 17.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):535–542. doi: 10.1097/QAI.0000000000002500

TABLE 2.

Prevalence and Predictors of Uptake and HIV Diagnostic Yield for HBT Versus CBT

HBT
CBT
Characteristic Mean (Range) or n (%) P

Caregivers’ initial preference of testing location (n = 492*) 115 (23) 377 (77)
 Eligible children per caregiver 2 (1–6) 2 (1–8) 0.005§
 Caregivers with 1 child 45 (18) 205 (82)
 Caregivers with 2 children 47 (28) 118 (72)
 Caregivers with 3+ children 23 (30) 54 (70)
Caregivers completing testing for at least 1 child (n = 347) 69 (20) 278 (80)
 Children tested per caregiver 2 (1–5) 1 (1–4) 0.0003§
 Caregivers with 1 child 33 (15) 185 (85)
 Caregivers with 2 children 24 (26) 70 (74)
 Caregivers with 3+ children 12 (34) 23 (66)
Children tested (n = 521) 123 (24) 398 (76)
 Child age (yr) 7 (0–12) 7 (0–12) 0.282§
 Prevalence of HIV infection 3 (2) 27 (7) 0.072
*

1 enrolled caregiver opted not to test their children.

4 of the 69 caregivers had initially chosen CBT, then switched to HBT

12 of the 278 caregivers had initially chosen HBT, then switched to CBT.

§

Wilcoxon rank-sum test comparing the age of children tested at home versus children tested in clinic.

χ2 test comparing proportion of children who tested HIV positive following HBT versus CBT.